Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

BioMarin

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of BioMarin's 2012 metabolic sales performance.

Deal Watch August 2016

Deal Watch August 2016 This high premium and the one for Cynapsys (see below) has led to speculation that other potential target mid cap biotech companies such as Vertex, BioMarin and Alexion could command higher ... The lead product is talazoparib, a PARP inhibitor, bought

Santhera facing long delay for muscular dystrophy drug in US

Santhera facing long delay for muscular dystrophy drug in US In recent months the FDA has rejected BioMarin's exon-skipping therapy Kyndrisa (drisapersen) - which has now been abandoned after also being turned down by the EMA - as well as PTC

BioMarin gives up on muscular dystrophy drug

BioMarin gives up on muscular dystrophy drug Makes ‘difficult but necessary’ decision to abandon exon-skipping therapy Kyndrisa. BioMarin has said it will stop development of its Duchenne muscular dystrophy (DMD) drug Kyndrisa after another regulatory knockback. ... The announcement marks the

Sanofi takeover bid rebuffed by Medivation

Sanofi takeover bid rebuffed by Medivation Meanwhile, Medivation has a well-regarded cancer pipeline headed by PARP inhibitor talazoparib (MDV3800) - licensed from BioMarin - in phase III trials for the treatment of patients with breast cancer whose BRCA

FDA rejects PTC's application for muscular dystrophy drug

FDA rejects PTC's application for muscular dystrophy drug Translarna is intended to treat DMD caused by nonsense mutations in the dystrophin gene and works via a slightly different mechanism to other DMD therapies coming through the pipeline, including

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics